Hospital General Universitario de Alicante -ko ikertzaileekin lankidetzan egindako argitalpenak (19)

2024

  1. Thrombotic risk and features of patients with inferior vena cava agenesis: a multicentre, retrospective, observational study

    The Lancet Haematology, Vol. 11, Núm. 8, pp. e606-e616

2018

  1. Enhancing the ‘real world’ prediction of cardiovascular events and major bleeding with the CHA 2 DS 2 -VASc and HAS-BLED scores using multiple biomarkers

    Annals of Medicine, Vol. 50, Núm. 1, pp. 26-34

2017

  1. Clinical perspectives on the management of bleeding in patients on oral anticoagulants: The DECOVER Study (DElphi Consensus on oral COagulation and therapy action reVERsa

    Emergencias, Vol. 29, Núm. 1, pp. 18-26

2016

  1. Real-life management of primary immune thrombocytopenia (ITP) in adult patients and adherence to practice guidelines

    Annals of Hematology, Vol. 95, Núm. 7, pp. 1089-1098

2010

  1. CALU A29809G polymorphism in coronary atherothrombosis: Implications for coronary calcification and prognosis

    Annals of Medicine, Vol. 42, Núm. 6, pp. 439-446

  2. Synergism between factor XII -4C>T and factor XIII Val34Leu polymorphisms in fibrinolytic therapy in acute myocardial infarction

    Thrombosis and Haemostasis

2009

  1. Antithrombin Cambridge ll (A384S) supports a role for antithrombin deficiency in arterial thrombosis

    Thrombosis and Haemostasis, Vol. 101, Núm. 3, pp. 483-486

2008

  1. Factor VII -323 decanucleotide D/I polymorphism in atrial fibrillation: Implications for the prothrombotic state and stroke risk

    Annals of Medicine, Vol. 40, Núm. 7, pp. 553-559

  2. Matrix metalloproteinases and tissue remodeling in hypertrophic cardiomyopathy

    American Heart Journal, Vol. 156, Núm. 1, pp. 85-91

2007

  1. A multimarker risk stratification approach to non-ST elevation acute coronary syndrome: Implications of troponin T, CRP, NT pro-BNP and fibrin D-dimer levels

    Journal of Internal Medicine, Vol. 262, Núm. 6, pp. 651-658

  2. Plasma angiogenin levels in acute coronary syndromes: Implications for prognosis

    European Heart Journal, Vol. 28, Núm. 24, pp. 3006-3011

  3. Prognostic value of annexin A5-1 C/T polymorphism in a long term follow-up after premature myocardial infarction [2]

    Journal of Thrombosis and Haemostasis

2005

  1. A pharmacogenetic effect of factor XIII valine 34 leucine polymorphism on fibrinolytic therapy for acute myocardial infarction

    Journal of the American College of Cardiology, Vol. 45, Núm. 1, pp. 25-29

  2. Five prothrombotic polymorphisms and the prevalence of premature myocardial infarction

    Haematologica, Vol. 90, Núm. 3, pp. 421-423

2004

  1. Effect of factor VII -323 Del/Ins polymorphism on the daily variability of factor VIIc and INR in steady anticoagulated patients with acenocoumarol [3]

    Journal of Thrombosis and Haemostasis

  2. Factor XIII Val34Leu polymorphism modulates the prothrombotic and inflammatory state associated with atrial fibrillation

    Journal of Molecular and Cellular Cardiology, Vol. 37, Núm. 3, pp. 699-704

  3. Mutations in the shutter region of antithrombin result in formation of disulfide-linked dimers and severe venous thrombosis

    Journal of Thrombosis and Haemostasis, Vol. 2, Núm. 6, pp. 931-939

  4. Short alleles of P-selectin glycoprotein ligand-1 protect against premature myocardial infarction

    American Heart Journal, Vol. 148, Núm. 4, pp. 602-605

2002

  1. A common polymorphism in the annexin V Kozak sequence (-1C>T) increases translation efficiency and plasma levels of annexin V, and decreases the risk of myocardial infarction in young patients

    Blood, Vol. 100, Núm. 6, pp. 2081-2086